Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sv7 Impact Medicine Fund Lp investment portfolio
Sv7 Impact Medicine Fund Lp has made numerous investments in companies such as Sitryx Therapeutics, Quell Therapeutics, and Alchemab Therapeutics within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Alchemab Therapeutics Ltd Alchemab Therapeutics develops antibody‑based medicines by mining naturally protective antibodies from long‑term disease survivors and other resilient individuals, using deep‑learning and biotechnology platforms to create therapies for cancer, neurodegenerative disorders and infectious diseases. | Healthcare & Life Sciences | London | Confirmed | 2025-11-28 |
| Quell Therapeutics Limited Quell Therapeutics develops engineered regulatory T‑cell (Treg) therapies to treat solid organ transplant rejection and autoimmune diseases, targeting the transplant and autoimmune patient markets. | Healthcare & Life Sciences | London | Confirmed | 2025-04-28 |
Shareholding changes (4)
Sv7 Impact Medicine Fund Lp's positions across portfolio companies2025
- SERIES A PREFERRED 9,424,254 → 0
- SERIES A-1 PREFERRED 0 → 9,424,254
- SERIES A-3 PREFERRED 0 → 1,318,982
- SERIES A PREFERRED SHARES 986,842 → 1,578,947